Lantheus Holdings (LNTH) Stock Price, Quote & News

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 978 671 8001

Fax: 978 671 8860

Website: www.lantheus.com

Address:

201 Burlington Road, South Building, Bedford, United States

SuperGreenToday Feb. 2 at 10:55 PM

$LNTH Share Price: $66.51 Contract Selected: Jul 17, 2026 $65 Calls Buy Zone: $7.39 – $9.13 Target Zone: $13.46 – $16.45 Potential Upside: 72% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

CharlieeMungerTWITS Feb. 2 at 6:59 PM

$LNTH $70 coming

0 · Reply

RadioIsotope25 Feb. 2 at 6:20 PM

$LNTH Lantheus owns significant equity in both Radiopharm Theranostics and Perspective Therapeutics $CATX $RADX

1 · Reply

SuperGreenToday Jan. 30 at 9:55 PM

$LNTH Share Price: $66.93 Contract Selected: Jul 17, 2026 $65 Calls Buy Zone: $8.07 – $9.97 Target Zone: $13.30 – $16.26 Potential Upside: 56% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

RadioIsotope25 Jan. 30 at 2:37 PM

Both $CATX and $RADX severely undervalued $LNTH owns 15% of each. $60 million market cap RADX with great Rad101 data and emerging data for potential her2 drug in rad202 coming shortly. Already showing better than expected tumor uptake that’s an $8 billion dollar market.

0 · Reply

Jcljack26 Jan. 29 at 6:42 PM

$CATX I think its getting bought out, I think $LNTH is buying up some of the OS then will make an offer much higher but will not cost them as much because they are buying most now. JMHO

1 · Reply

Jcljack26 Jan. 29 at 5:40 PM

$LNTH Is LNTH making an offer for the rest of $CATX anyone here know? TIA

0 · Reply

CharlieeMungerTWITS Jan. 29 at 1:31 PM

$LNTH this stock is so undercover given the watchers

0 · Reply

RadioIsotope25 Jan. 28 at 3:21 PM

$RADX Upside in Aktis is $4 billion equals 300%. Their market cap is $1 billion already they have the halo ipo valuation. Upside in Radiopharm Theranostics is minimum $200-500 million could be $1 to 2 billion. At $60 million market cap you calculate the upside. $AKTS $LNTH

0 · Reply

CharlieeMungerTWITS Jan. 23 at 1:53 PM

$LNTH March back to $70

1 · Reply

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

Jan 2, 2026, 8:00 AM EST - 4 weeks ago

Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies

Dec 7, 2025, 11:21 AM EST - 2 months ago

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)

Nov 13, 2025, 9:28 AM EST - 2 months ago

The Bottom Fishing Club - Lantheus Holdings: Interesting Buy Momentum Supporting Price

Nov 13, 2025, 1:50 AM EST - 2 months ago

Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update

BRBR MMSI MNDY PI POWL PRM RMBS

Nov 7, 2025, 9:48 AM EST - 3 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Nov 6, 2025, 5:56 PM EST - 3 months ago

Lantheus Holdings, Inc. (LNTH) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:02 AM EST - 3 months ago

Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 11:59 AM EST - 3 months ago

LNTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Oct 30, 2025, 3:58 PM EDT - 3 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit – LNTH

Oct 28, 2025, 9:44 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Oct 27, 2025, 10:08 AM EDT - 3 months ago

LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) DEADLINE ALERT Bernstein Liebhard LLP Reminds Lantheus Holdings, Inc. Investors of Upcoming Deadline

Oct 23, 2025, 1:03 PM EDT - 3 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lantheus

Oct 23, 2025, 8:30 AM EDT - 3 months ago

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time

Oct 15, 2025, 4:35 PM EDT - 3 months ago

LANTHEUS DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Lantheus Holdings Investors to Contact the Firm Before the November 10th Deadline

Oct 14, 2025, 6:07 AM EDT - 3 months ago

Lantheus Holdings: Not An Easy Buy, But The Company Continues To Create Value

Oct 6, 2025, 8:45 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Holdings, Inc. Lawsuit - LNTH

Sep 25, 2025, 8:45 AM EDT - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Lawsuit - LNTH

Sep 24, 2025, 1:00 AM EDT - 4 months ago

Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan

Sep 22, 2025, 5:29 AM EDT - 4 months ago

Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

Sep 19, 2025, 6:33 PM EDT - 4 months ago

Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information

Sep 10, 2025, 8:00 PM EDT - 5 months ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (LNTH)

Sep 10, 2025, 10:54 AM EDT - 5 months ago

LNTH LAWSUIT: Lantheus Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Sep 9, 2025, 10:09 AM EDT - 5 months ago

Lantheus Holdings, Inc. (LNTH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 8:55 PM EDT - 5 months ago

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

Aug 6, 2025, 9:09 PM EDT - 6 months ago

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

SuperGreenToday Feb. 2 at 10:55 PM

0 · Reply

CharlieeMungerTWITS Feb. 2 at 6:59 PM

$LNTH $70 coming

0 · Reply

RadioIsotope25 Feb. 2 at 6:20 PM

$LNTH Lantheus owns significant equity in both Radiopharm Theranostics and Perspective Therapeutics $CATX $RADX

1 · Reply

SuperGreenToday Jan. 30 at 9:55 PM

0 · Reply

RadioIsotope25 Jan. 30 at 2:37 PM

0 · Reply

Jcljack26 Jan. 29 at 6:42 PM

$CATX I think its getting bought out, I think $LNTH is buying up some of the OS then will make an offer much higher but will not cost them as much because they are buying most now. JMHO

1 · Reply

Jcljack26 Jan. 29 at 5:40 PM

$LNTH Is LNTH making an offer for the rest of $CATX anyone here know? TIA

0 · Reply

CharlieeMungerTWITS Jan. 29 at 1:31 PM

$LNTH this stock is so undercover given the watchers

0 · Reply

RadioIsotope25 Jan. 28 at 3:21 PM

0 · Reply

CharlieeMungerTWITS Jan. 23 at 1:53 PM

$LNTH March back to $70

1 · Reply

RadioIsotope25 Jan. 22 at 4:50 PM

Radiopharm’s New Phase 1 Imaging Trial Puts LRRC15-Targeted Radiotherapy in Focus - TipRanks.com $RADX $LNTH https://www.tipranks.com/news/company-announcements/radiopharms-new-phase-1-imaging-trial-puts-lrrc15-targeted-radiotherapy-in-focus

1 · Reply

RadioIsotope25 Jan. 21 at 11:52 PM

Rad101 shows tumors that MRI’s can’t. 300,000 patient population.. would be 3rd largest revenue radiopharmaceutical imaging agent in world. $RADX $LNTH $AKTS

0 · Reply

RadioIsotope25 Jan. 21 at 6:43 PM

$RADX Re: Lantheus- 20:24 from Conf today; Uh they are the largest investor with 15% of the company, Um they don’t have a board seat. They don’t have first right of refusal. So they play the investor roles. They are a five billion dollar company. So they are looking at our products and I am sure they are interested in many of them. Our job is to advance and prove products can be successful and potentially that collaboration can go. $LNTH $AKTS

1 · Reply

RadioIsotope25 Jan. 21 at 3:42 PM

Radiopharm Theranostics, Ltd. (NASDAQ: $RADX) (ASX: RAD) - YouTube $AKTS $IBRX $IOVA $LNTH https://www.youtube.com/watch?v=XVL6708YTvU

1 · Reply

CharlieeMungerTWITS Jan. 21 at 2:26 AM

$LNTH

0 · Reply

TPTradingCo Jan. 20 at 11:30 PM

$LNTH $80 before Groundhog Day…

0 · Reply

CharlieeMungerTWITS Jan. 20 at 7:31 PM

$LNTH gap filled?

1 · Reply

RadioIsotope25 Jan. 20 at 4:51 PM

Worth a minimum $9.30 that’s what Lantheus paid. If rad202 shows meaningful response at 75 mci this can be asymmetrical… No borrow Same warheads as pluvicto and Lutathera Ceo comes from Novartis Market cap tiny at $60 million when Aktis sits over a billion. Rad101 already has great phase 2 b data and they gonna start phase 3 in 4th quarter. $750 million global imaging asset. $IOVA $LNTH $IBRX $AKTS

0 · Reply

SuperGreenToday Jan. 20 at 12:12 AM

$LNTH Share Price: $64.24 Contract Selected: Dec 18, 2026 $65 Calls Buy Zone: $10.12 – $12.50 Target Zone: $18.26 – $22.32 Potential Upside: 71% ROI Time to Expiration: 332 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Live2ride Jan. 16 at 3:36 PM

$LNTH Looks like we are going to fill the gap at $63.50

1 · Reply

CharlieeMungerTWITS Jan. 15 at 12:56 PM

$LNTH cooling down for the next leg up break that $70 resistance

0 · Reply

WilliamBalding588 Jan. 12 at 6:04 PM

$LNTH $ABT Diagnostics focus

0 · Reply

Market Cap	4.44B
Revenue (ttm)	1.53B
Net Income (ttm)	312.44M
EPS (ttm)	N/A
PE Ratio	13.47
Forward PE	14.19
Profit Margin	20.37%
Debt to Equity Ratio	0.51

Volume	778,500
Avg Vol	972,968
Day's Range	N/A - N/A
Shares Out	66.31M
Stochastic %K	38%
Beta	-0.11
Analysts	Strong Sell
Price Target	$83.46